Atopalm Deep Penetrating Pain Relieving
NDC Package 51141-0235-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Atopalm Deep Penetrating Pain Relieving is use only as directedAdults and children 12 years of age and olderapply to affected area not more than 3 to 4 times dailyChildren under 12 years of ageask a doctor. Marketed by Neopharm Co., Ltd., this product is identified by NDC 51141-0235 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
51141-0235-4
Package Description
1 TUBE in 1 CARTON / 113 g in 1 TUBE
Product Code
51141-0235
11-Digit Billing Format
51141023504
RxNorm Crosswalk
  • RxCUI: 1485493 - ATOPALM Pain Relieving 10 % / 15 % Topical Cream
  • RxCUI: 1485493 - menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream [Atopalm Pain Relief]
  • RxCUI: 1485493 - Atopalm Deep Penetrating Pain Relieving (menthol 10 % / methyl salicylate 15 % ) Topical Cream
  • RxCUI: 1485493 - Atopalm Pain Relief (menthol 100 MG/ML / methyl salicylate 150 MG/ML) Topical Cream
  • RxCUI: 1485493 - Atopalm Pain Relieving (menthol 10 % / methyl salicylate 15 % ) Topical Cream

Clinical Specifications

Proprietary Name
Atopalm Deep Penetrating Pain Relieving
Dosage Form
-
Usage Information
Use only as directedAdults and children 12 years of age and olderapply to affected area not more than 3 to 4 times dailyChildren under 12 years of ageask a doctor

Regulatory & Marketing

Labeler Name
Neopharm Co., Ltd.
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
01-17-2012
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51141-0235-4 identifies a specific commercial package of 1 tube in 1 carton / 113 g in 1 tube of Atopalm Deep Penetrating Pain Relieving, labeled by Neopharm Co., Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neopharm Co., Ltd. on January 17, 2012. The current certification is valid through December 31, 2017.

How is this Neopharm Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51141023504. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51141-0235-4
11-Digit CMS (5-4-2)
51141-0235-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.